Blog
Stellus Capital (SCM) Q1 Earnings Meet Estimates
Stellus Capital (SCM) came out with quarterly earnings of $0.37 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $0.44 per share a year ago. These figures are
Bolt Biotherapeutics, Inc. (BOLT) Reports Q1 Loss, Tops Revenue Estimates
Bolt Biotherapeutics, Inc. (BOLT) came out with a quarterly loss of $0.29 per share versus the Zacks Consensus Estimate of a loss of $0.34. This compares to loss of $0.28 per share a year ago. These
Getty Images Holdings, Inc. (GETY) Reports Q1 Loss, Lags Revenue Estimates
Getty Images Holdings, Inc. (GETY) came out with a quarterly loss of $0.14 per share versus the Zacks Consensus Estimate of $0.03. This compares to earnings of $0.01 per share a year ago. These
Karyopharm Therapeutics (KPTI) Reports Q1 Loss, Lags Revenue Estimates
Karyopharm Therapeutics (KPTI) came out with a quarterly loss of $2.77 per share versus the Zacks Consensus Estimate of a loss of $4.21. This compares to loss of $4.80 per share a year ago. These
Acadia Healthcare (ACHC) Beats Q1 Earnings Estimates
Acadia Healthcare (ACHC) came out with quarterly earnings of $0.40 per share, beating the Zacks Consensus Estimate of $0.35 per share. This compares to earnings of $0.84 per share a year ago. These
Magnachip (MX) Reports Q1 Loss, Tops Revenue Estimates
Magnachip (MX) came out with a quarterly loss of $0.10 per share versus the Zacks Consensus Estimate of a loss of $0.28. This compares to loss of $0.28 per share a year ago. These figures are
Rigetti Computing, Inc. (RGTI) Reports Q1 Loss, Lags Revenue Estimates
Rigetti Computing, Inc. (RGTI) came out with a quarterly loss of $0.08 per share versus the Zacks Consensus Estimate of a loss of $0.05. This compares to loss of $0.14 per share a year ago. These
MidCap Financial Investment (MFIC) Q1 Earnings and Revenues Lag Estimates
MidCap Financial Investment (MFIC) came out with quarterly earnings of $0.37 per share, missing the Zacks Consensus Estimate of $0.39 per share. This compares to earnings of $0.44 per share a year
Maravai LifeSciences Holdings, Inc. (MRVI) Reports Q1 Loss, Tops Revenue Estimates
Maravai LifeSciences Holdings, Inc. (MRVI) came out with a quarterly loss of $0.08 per share versus the Zacks Consensus Estimate of a loss of $0.07. This compares to loss of $0.02 per share a year
CompoSecure, Inc. (CMPO) Tops Q1 Earnings Estimates
CompoSecure, Inc. (CMPO) came out with quarterly earnings of $0.25 per share, beating the Zacks Consensus Estimate of $0.19 per share. This compares to earnings of $0.25 per share a year ago. These
American Public Education (APEI) Beats Q1 Earnings and Revenue Estimates
American Public Education (APEI) came out with quarterly earnings of $0.41 per share, beating the Zacks Consensus Estimate of $0.15 per share. This compares to loss of $0.06 per share a year ago
Peraso (PRSO) Reports Q1 Loss, Tops Revenue Estimates
Peraso (PRSO) came out with a quarterly loss of $0.08 per share versus the Zacks Consensus Estimate of a loss of $0.16. This compares to loss of $0.83 per share a year ago. These figures are
Power Integrations (POWI) Q1 Earnings Surpass Estimates
Power Integrations (POWI) came out with quarterly earnings of $0.31 per share, beating the Zacks Consensus Estimate of $0.28 per share. This compares to earnings of $0.18 per share a year ago. These
Stereotaxis Inc. (STXS) Reports Q1 Loss, Tops Revenue Estimates
Stereotaxis Inc. (STXS) came out with a quarterly loss of $0.07 per share in line with the Zacks Consensus Estimate. This compares to loss of $0.06 per share a year ago. These figures are adjusted
Simon Property (SPG) Q1 FFO Surpass Estimates
Simon Property (SPG) came out with quarterly funds from operations (FFO) of $2.95 per share, beating the Zacks Consensus Estimate of $2.91 per share. This compares to FFO of $3.56 per share a year
Plug Power (PLUG) Reports Q1 Loss, Tops Revenue Estimates
Plug Power (PLUG) came out with a quarterly loss of $0.21 per share versus the Zacks Consensus Estimate of a loss of $0.20. This compares to loss of $0.43 per share a year ago. These figures are
FibroGen (FGEN) Reports Q1 Loss, Tops Revenue Estimates
FibroGen (FGEN) came out with a quarterly loss of $0.16 per share versus the Zacks Consensus Estimate of $0.03. This compares to loss of $0.33 per share a year ago. These figures are adjusted for
PennantPark (PNNT) Q2 Earnings and Revenues Miss Estimates
PennantPark (PNNT) came out with quarterly earnings of $0.18 per share, missing the Zacks Consensus Estimate of $0.19 per share. This compares to earnings of $0.22 per share a year ago. These
HighPeak Energy, Inc. (HPK) Q1 Earnings and Revenues Beat Estimates
HighPeak Energy, Inc. (HPK) came out with quarterly earnings of $0.31 per share, beating the Zacks Consensus Estimate of $0.22 per share. This compares to earnings of $0.37 per share a year ago
DaVita HealthCare (DVA) Q1 Earnings and Revenues Beat Estimates
DaVita HealthCare (DVA) came out with quarterly earnings of $2 per share, beating the Zacks Consensus Estimate of $1.75 per share. This compares to earnings of $2.38 per share a year ago. These
Aquestive Therapeutics (AQST) Reports Q1 Loss, Lags Revenue Estimates
Aquestive Therapeutics (AQST) came out with a quarterly loss of $0.24 per share versus the Zacks Consensus Estimate of a loss of $0.17. This compares to loss of $0.17 per share a year ago. These
Assertio (ASRT) Reports Q1 Loss, Misses Revenue Estimates
Assertio (ASRT) came out with a quarterly loss of $0.14 per share versus the Zacks Consensus Estimate of a loss of $0.06. This compares to earnings of $0.04 per share a year ago. These figures are
Quanterix Corporation (QTRX) Reports Q1 Loss, Tops Revenue Estimates
Quanterix Corporation (QTRX) came out with a quarterly loss of $0.53 per share versus the Zacks Consensus Estimate of a loss of $0.69. This compares to loss of $0.26 per share a year ago. These
Cue Biopharma, Inc. (CUE) Reports Q1 Loss, Misses Revenue Estimates
Cue Biopharma, Inc. (CUE) came out with a quarterly loss of $0.17 per share versus the Zacks Consensus Estimate of a loss of $0.14. This compares to loss of $0.25 per share a year ago. These figures
Enanta Pharmaceuticals (ENTA) Reports Q2 Loss, Misses Revenue Estimates
Enanta Pharmaceuticals (ENTA) came out with a quarterly loss of $1.06 per share versus the Zacks Consensus Estimate of a loss of $1.04. This compares to loss of $1.47 per share a year ago. These


